Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining 1.61% today. In the last week its performance is 4.80%, and 5.07% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 52.7, so today’s gain of 1.61% is a significant step towards its target price. The GAP today is therefore 0.87%.
Zoetis Inc. (NYSE:ZTS), has a market cap of 24860.05, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 91.70%.
At the current price of 49.98, it has a dividend yield of 0.76%, and its target price is 52.7. This is with a profit margin of 7.80%, and total debt/equity of 3.84. Zoetis Inc. (NYSE:ZTS) has a P/E of 66.02, as well as a forward P/E of 21.77.
With a current EPS of 0.76, and a forecasted EPS growth for next year at 22.91%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 25.10%. For the next five years EPS growth is projected to be 12.58%.
Performance for the year is 7.15%. Since its IPO date on 2/1/2013, the total performance to date is 4.96%.
Volume today for Zoetis Inc. (NYSE:ZTS), is 2617900, while its average volume is 3381.6. Whilst the total gain today was 1.61%, it did have a day high of 1.42%.
Volatility for this week has been at 1.22%, and 1.57% for the month. The 52-week low for Zoetis Inc., ZTS has been 33.56%, while the 52-week-high has reached 0.18%.
Looking at its return of investments, which is 5.70%, and its return on assets is 5.30%. Zoetis Inc. (NYSE:ZTS) has an operating margin of 13.40%. With a sales growth of 5.40% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is 3.83, and has a current ratio of 2.8 and 1.6 for quick ratio.
So what is the value of Zoetis Inc.? Well its PEG is 5.25, and the P/S is 5.15, along with a P/B of 21.36. Meanwhile it has a p/cash of 36.83.